Merck Manual

Please confirm that you are a health care professional

honeypot link

Metabolic Syndrome

(Syndrome X; Insulin Resistance Syndrome)

By

Shauna M. Levy

, MD, MS, Tulane University School of Medicine;


Michelle Nessen

, MD, Tulane University School of Medicine

Reviewed/Revised Nov 2023
View PATIENT EDUCATION
Topic Resources

Metabolic syndrome is characterized by a large waist circumference (due to excess abdominal adipose tissue), hypertension, abnormal fasting plasma glucose or insulin resistance, and dyslipidemia. Causes, complications, diagnosis, and treatment are similar to those of obesity Obesity Obesity is a chronic, multifactorial, relapsing disorder characterized by excess body weight and defined as a body mass index (BMI) of ≥ 30 kg/m2. Complications include cardiovascular disorders... read more .

The incidence of metabolic syndrome often parallels that of obesity and type 2 diabetes. The prevalence of metabolic syndrome increases with age, and in one United States study, it was approximately 23% in the general population and was 44% for people aged 60 to 69 years and 42% in those aged ≥ 70 years (1 Reference Metabolic syndrome is characterized by a large waist circumference (due to excess abdominal adipose tissue), hypertension, abnormal fasting plasma glucose or insulin resistance, and dyslipidemia... read more ). Children and adolescents can develop metabolic syndrome, but in these age groups, no strict definition is established.

Development of metabolic syndrome depends on distribution as well as amount of adipose tissue. Excess central adiposity (called apple shape), particularly when it results in a high waist-to-hip ratio (reflecting a relatively low muscle-to-fat mass ratio), increases risk. The syndrome is less common among people who have excess subcutaneous fat around the hips (called pear shape) and a low waist-to-hip ratio (reflecting a higher muscle-to-fat mass ratio).

Some experts think that chronic stress causes hormonal changes that contribute to abdominal obesity, insulin resistance, and low blood lipid (HDL) levels.

Risks of metabolic syndrome include

Reference

  • 1. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287 (3):356–359, 2002. doi: 10.1001/jama.287.3.356

Diagnosis of Metabolic Syndrome

  • Waist circumference and blood pressure

  • Fasting plasma glucose and a lipid profile

Screening for metabolic syndrome is important. A family history plus measurement of waist circumference and blood pressure are part of routine care. If patients with a family history of type 2 diabetes mellitus, particularly those 40 years, have a waist circumference greater than that recommended for their race and sex, fasting plasma glucose and a lipid profile must be determined.

Metabolic syndrome has many different definitions, but it is most often diagnosed when 3 of the following are present (see table ):

Table

Treatment of Metabolic Syndrome

  • Heart-healthy diet and physical activity

  • Medications such as metformin and statins

  • Anti-obesity medications and metabolic and bariatric surgery

  • Smoking cessation

  • Stress management

Optimally, a management approach based on a heart-healthy diet and regular physical activity results in weight loss; physical activity includes a combination of aerobic activity and resistance training, reinforced with behavioral therapy. Metformin, an insulin sensitizer, or a thiazolidinedione (eg, rosiglitazone, pioglitazone) may be useful. Weight loss of 7% may be sufficient to reverse the syndrome, but if not, each feature of the syndrome should be managed to achieve recommended targets; available medications are very effective.

Other cardiovascular risk factors (eg, smoking cessation) also need to be managed. Increased physical activity has cardiovascular benefits even if weight is not lost.

Patients with dyslipidemia may be treated with statins.

Stress management (eg, deep breathing exercises, meditation, psychologic support, counseling) is recommended.

Key Points

  • Excess abdominal adiposity leads to abnormal fasting plasma glucose or insulin resistance, dyslipidemias, and hypertension; having 3 or more of these conditions defines metabolic syndrome.

  • Metabolic syndrome is extremely common (eg, prevalence in the United States of possibly > 40% in people > 60 years).

  • Determine waist circumference, blood pressure, fasting plasma glucose, and lipid profile.

  • Emphasize following a healthy diet and exercising, and manage cardiovascular risk factors; if these measures are not completely effective, consider use of anti-obesity medications and/or metabolic and bariatric surgery.

Drugs Mentioned In This Article

Drug Name Select Trade
Afrezza, Exubera
RYPLAZIM
Androderm, AndroGel, Andro-L.A., Aveed, AXIRON, Delatestryl, Depo-Testosterone, FORTESTA, JATENZO, KYZATREX, Natesto, STRIANT, Testim, Testoderm, Testopel, TLANDO, Virilon, Vogelxo, XYOSTED
Fortamet, Glucophage, Glucophage XR, Glumetza, Riomet, RIOMET ER
Avandia
Actos
alli, Xenical
Adipex-P, Atti-Plex P , Atti-Plex P Spansule , Fastin, Ionamin, Lomaira , Pro-Fast HS, Pro-Fast SA, Pro-Fast SR , Suprenza, Tara-8
Saxenda, Victoza
View PATIENT EDUCATION
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz! 
iOS ANDROID
iOS ANDROID
iOS ANDROID
TOP